Publication | Closed Access

Nilotinib reduced the viability of human ovarian cancer cells via mitochondria-dependent apoptosis, independent of JNK activation

MedicineApoptosisPharmacologyCell DeathAnti-cancer AgentMitochondria-dependent ApoptosisTumor SuppressorOncologyCell BiologyOvarian CancerJnk Activation